Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
BBLG is expected to report earnings to rise 5.88% to -18 cents per share on March 03
Q4'26
Est.
$-0.18
Q3'26
Beat
by $0.02
Q2'26
Missed
by $0.04
Q4'25
Beat
by $6.98
Q3'25
Beat
by $7.55
The last earnings report on October 26 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 185.00 shares outstanding, the current market capitalization sits at 918.87K.